Novel Causes of Generalized Glucocorticoid Resistance

Abstract

Glucocorticoid resistance is a rare condition characterized by generalized, partial, target-tissue insensitivity to glucocorticoids. Compensatory elevations in circulating adrenocorticotropic hormone (ACTH) concentrations lead to increased secretion of cortisol and adrenal steroids with mineralocorticoid and/or androgenic activity, but no clinical evidence of hypercortisolism. The clinical spectrum of the condition is broad, ranging from asymptomatic to severe cases of hyperandrogenism, fatigue and/or mineralocorticoid excess. The molecular basis of glucocorticoid resistance has been ascribed to mutations in the human glucocorticoid receptor (hGR) gene, which impair glucocorticoid signal transduction, thereby altering tissue sensitivity to glucocorticoids. The study of functional defects of natural hGR mutants enhances our understanding of the molecular mechanisms of hGR action and highlights the importance of integrated cellular and molecular signaling mechanisms for maintaining homeostasis and preserving normal physiology.

Key words

Glucocorticoid receptor (GR) - glucocorticoid resistance - mutations - human glucocorticoid receptor (hGR) gene

References

• 1 Vingerhoeds AC, Thijssen JH, Schwarz F. Spontaneous hypercortisolism without Cushing's syndrome.  J Clin Endocrinol Metab. 1976;  43 1128-1133
• 2 Chrousos GP, Vingerhoeds A, Brandon D, Eil C, Pugeat M, DeVroede M, Loriaux DL, Lipsett MB. Primary cortisol resistance in man. A glucocorticoid receptor-mediated disease.  J Clin Invest. 1982;  69 1261-1269
• 3 Chrousos GP, Detera-Wadleigh SD, Karl M. Syndromes of glucocorticoid resistance.  Ann Intern Med. 1993;  119 1113-1124
• 4 Kino T, Chrousos GP. Glucocorticoid and mineralocorticoid resistance/hypersensitivity syndromes.  J Endocrinol. 2001;  169 437-445
• 5 Chrousos GP. Hormone Resistance and Hypersensitivity States. In: Modern Endocrinology Series. Chrousos GP, Olefsky JM, Samols E (eds). Philadelphia, PA: Lippincott, Williams & Wilkins 2002: 542
• 6 Kino T, Vottero A, Charmandari E, Chrousos GP. Familial/sporadic glucocorticoid resistance syndrome and hypertension.  Ann N Y Acad Sci. 2002;  970 101-111
• 7 Kino T, De Martino MU, Charmandari E, Mirani M, Chrousos GP. Tissue glucocorticoid resistance/hypersensitivity syndromes.  J Steroid Biochem Mol Biol. 2003;  85 457-467
• 8 Charmandari E, Kino T, Chrousos GP. Familial/sporadic glucocorticoid resistance: clinical phenotype and molecular mechanisms.  Ann N Y Acad Sci. 2004;  1024 168-181
• 9 Karl M, Lamberts SW, Koper JW, Katz DA, Huizenga NE, Kino T, Haddad BR, Hughes MR, Chrousos GP. Cushing's disease preceded by generalized glucocorticoid resistance: clinical consequences of a novel, dominant-negative glucocorticoid receptor mutation.  Proc Assoc Am Physicians. 1996;  108 296-307
• 10 Hurley DM, Accili D, Stratakis CA, Karl M, Vamvakopoulos N, Rorer E, Constantine K, Taylor SI, Chrousos GP. Point mutation causing a single amino acid substitution in the hormone binding domain of the glucocorticoid receptor in familial glucocorticoid resistance.  J Clin Invest. 1991;  87 680-686
• 11 Karl M, Lamberts SW, Detera-Wadleigh SD, Encio IJ, Stratakis CA, Hurley DM, Accili D, Chrousos GP. Familial glucocorticoid resistance caused by a splice site deletion in the human glucocorticoid receptor gene.  J Clin Endocrinol Metab. 1993;  76 683-689
• 12 Malchoff DM, Brufsky A, Reardon G, McDermott P, Javier EC, Bergh CH, Rowe D, Malchoff CD. A mutation of the glucocorticoid receptor in primary cortisol resistance.  J Clin Invest. 1993;  91 1918-1925
• 13 Kino T, Stauber RH, Resau JH, Pavlakis GN, Chrousos GP. Pathologic human GR mutant has a transdominant negative effect on the wild-type GR by inhibiting its translocation into the nucleus: importance of the ligand-binding domain for intracellular GR trafficking.  J Clin Endocrinol Metab. 2001;  86 5600-5608
• 14 Ruiz M, Lind U, Gafvels M, Eggertsen G, Carlstedt-Duke J, Nilsson L, Holtmann M, Stierna P, Wikstrom AC, Werner S. Characterization of two novel mutations in the glucocorticoid receptor gene in patients with primary cortisol resistance.  Clin Endocrinol (Oxf). 2001;  55 363-371
• 15 Mendonca BB, Leite MV, de Castro M, Kino T, Elias LL, Bachega TA, Arnhold IJ, Chrousos GP, Latronico AC. Female pseudohermaphroditism caused by a novel homozygous missense mutation of the GR gene.  J Clin Endocrinol Metab. 2002;  87 1805-1809
• 16 Vottero A, Kino T, Combe H, Lecomte P, Chrousos GP. A novel, C-terminal dominant negative mutation of the GR causes familial glucocorticoid resistance through abnormal interactions with p160 steroid receptor coactivators.  J Clin Endocrinol Metab. 2002;  87 2658-2667
• 17 Charmandari E, Kino T, Vottero A, Souvatzoglou E, Bhattacharyya N, Chrousos GP. Natural glucocorticoid receptor mutants causing generalized glucocorticoid resistance: Molecular genotype, genetic transmission and clinical phenotype.  J Clin Endocrinol Metab. 2004;  89 1939-1949
• 18 Charmandari E, Kino T, Ichijo T, Zachman K, Alatsatianos A, Chrousos GP. Functional characterization of the natural human glucocorticoid receptor (hGR) mutants hGRalphaR477 H and hGRalphaG679S associated with generalized glucocorticoid resistance.  J Clin Endocrinol Metab. 2006;  91 1535-1543
• 19 Charmandari E, Raji A, Kino T, Ichijo T, Tiulpakov A, Zachman K, Chrousos GP. A novel point mutation in the ligand-binding domain (LBD) of the human glucocorticoid receptor (hGR) causing generalized glucocorticoid resistance: the importance of the C terminus of hGR LBD in conferring transactivational activity.  J Clin Endocrinol Metab. 2005;  90 3696-3705
• 20 Bledsoe RK, Montana VG, Stanley TB, Delves CJ, Apolito CJ, McKee DD, Consler TG, Parks DJ, Stewart EL, Willson TM, Lambert MH, Moore JT, Pearce KH, Xu HE. Crystal structure of the glucocorticoid receptor ligand binding domain reveals a novel mode of receptor dimerization and coactivator recognition.  Cell. 2002;  110 93-105
• 21 Kauppi B, Jakob C, Farnegardh M, Yang J, Ahola H, Alarcon M, Calles K, Engstrom O, Harlan J, Muchmore S, Ramqvist AK, Thorell S, Ohman L, Greer J, Gustafsson JA, Carlstedt-Duke J, Carlquist M. The three-dimensional structures of antagonistic and agonistic forms of the glucocorticoid receptor ligand-binding domain: RU-486 induces a transconformation that leads to active antagonism.  J Biol Chem. 2003;  278 22748-22754
• 22 Charmandari E, Kino T, Ichijo T, Jubiz W, Zachman K, Mejia L, Chrousos GP. A novel point mutation in Helix 11 of the ligand-binding domain of the human glucocorticoid receptor gene causing generalized glucocorticoid resistance. Poster presentation at the 88th Endocrine Society Annual Meeting. 2006 Boston, Massachusetts, USA

Correspondence